Dr. David Samadi has a SMART Approach to Cancer Treatment

Raised in Iran until 1979, Dr. David Samadi is a celebrity doctor who can be found on Fox News every Sunday as part of the House Call segment as well as at Lenox Hill Hospital where he practices robotic surgery to treat men with prostate cancer. His talent for this field is so renowned that not only is he the Chief of Robotic Surgery, but also the Chairman of Urology. His 89% success rate for his over 7,000 robotic surgeries performed has a lot to do with the fantastic team that he brought with him after his move from Mount Sinai Medical Center in 2011. The Samadi Modified Advanced Robotic Technique is a method developed by Samadi that decreases the risks of incontinence and impotence after a prostatectomy by saving the nerves of his patients.

Dr. David Samadi insists on treating both his team and his patients like family and despite his popularity, he takes the time to check on every single one of them before he leaves at the end of his busy work day.

After leaving Iran for Belgium following the Iranian Revolution, Dr. David Samadi continued his childhood education in London as well before settling in New York. A graduate of the Stony Brook School of Medicine, he also trained at the Montefiore Medical Center, Albert Einstein College of Medicine, Memorial Sloan Kettering Cancer Center, and Henri Mondor Hospital. Dr. David Samadi has extensive knowledge of oncology, proctology, and urology due to his dedication to education.

The world-renowned doctor has been the recipient of several honors in his lifetime. In 2014, Dr. David Samadi was named a New York Super Doctor as well as one of America’s Top Doctors for Cancer from 2009 to 2014. As a much-loved doctor, he has also been given the Vitals Patients’ Choice Award several times, an honor that is given based on the ratings of his patients. Vitals also presented him with the Most Compassionate Doctor Certification in both 2010 and 2011. New York Magazine named him one of the Best Doctors in the area several times from 2009 to 2015 as well.

To know more visit @: www.huffingtonpost.com/author/dr-david-samadi

Cancer Treatment Centers of America Partner with Others to Establish a Clinical Pathway

Cancer Treatment Centers of America was founded in 1988. This company became started on finding a personalized and patient-centered approach to the treatment and care of cancer patients. Cancer Treatment Centers of America (CTCA) is fully dedicated to providing a combination of different treatments that is specifically tailored to the different needs of each patient individually.

American cancer treatment centers as well as a couple of other companies, NantHealth and Allscripts, are working together to find a custom solution that will enable eviti to have access to all of the clinical workflows of Allscripts electronic health record. Eviti is a part of NantHealth and it is a support solution for clinical decisions. With the integration of this, Clinical Pathways Program will be able to help inform the process of cancer treatment without interrupting the workflow of the physicians.

As stated on Wikipedia, Clinical Pathways is able to present physicians and patients with treatment options that are appropriate for them specifically. It also keeps up with the new data and all of the new oncology research, which will in turn eliminate the clinicians guesswork. It provides many different treatment options that are all customized to the standard of care by the CTCA and it gives the patients the ability to review these options and choose which they prefer.

Clinical Pathways was designed with the patients specifically in mind. Once the treatment platform becomes engaged it provides numerous things. It will provide treatment regimens that are customized and specific for each individual patient. It will compare each treatment option and include the costs. It offers patients with access to guidelines that are up-to-date as well as the rate of response, the adverse side effects and even the amount of toxicity. This pathway creates a greater amount of transparency around the selection as well as the care delivery of the cancer therapies.

For further information follow Cancer Treatment Centers of America on Twitter.